Teva Neuroscience, Inc. Release: Now Available In Canada, AZILECT(TM) -- The Only, Once-A-Day Treatment For Parkinson’s Disease

MONTREAL, Sept. 20 /CNW Telbec/ - Teva Neuroscience announced today the launch of AZILECT(TM) (rasagiline mesylate tablets), the first and the only once-daily treatment for Parkinson's disease (PD) now available by prescription in pharmacies throughout Canada. This is important news for those living with PD who are taking their PD medications up to five times/day.